Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-26-016858
Filing Date
2026-04-15
Accepted
2026-04-15 17:01:33
Documents
100
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K form10-k.htm   iXBRL 10-K 2869028
2 EX-4.1 ex4-1.htm EX-4.1 53915
3 EX-19.1 ex19-1.htm EX-19.1 80390
4 EX-23.1 ex23-1.htm EX-23.1 2687
5 EX-23.2 ex23-2.htm EX-23.2 3233
6 EX-31.1 ex31-1.htm EX-31.1 17782
7 EX-31.2 ex31-2.htm EX-31.2 17731
8 EX-32.1 ex32-1.htm EX-32.1 10578
9 EX-32.2 ex32-2.htm EX-32.2 8743
  Complete submission text file 0001493152-26-016858.txt   12269844

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE cdt-20251231.xsd EX-101.SCH 89802
11 XBRL CALCULATION FILE cdt-20251231_cal.xml EX-101.CAL 94638
12 XBRL DEFINITION FILE cdt-20251231_def.xml EX-101.DEF 388973
13 XBRL LABEL FILE cdt-20251231_lab.xml EX-101.LAB 720179
14 XBRL PRESENTATION FILE cdt-20251231_pre.xml EX-101.PRE 552827
103 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1885043
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CDT Equity Inc. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41245 | Film No.: 26864799
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)